Stem Cell Program Leadership

Richard Gregory, PhD

Richard Gregory, PhD
Principal Investigator, Boston Children's Hospital
Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Richard I. Gregory, Ph.D., is Professor in the Departments of Biological Chemistry and Molecular Pharmacology, and Pediatrics at Harvard Medical School, and Principal Investigator in The Stem Cell Program in the Division of Hematolgy/Oncology at Boston Children’s Hospital. He is also Principal faculty member of The Harvard Stem Cell Institute, and co-Director and executive committee member of the Harvard Initiative for RNA Medicine.

Dr. Gregory received a Ph.D. from Cambridge University in 2001, and his postdoctoral work was performed at the Fox Chase Cancer Center and the Wistar Institute, Philadelphia. Dr. Gregory’s postdoctoral research focused on mechanisms of miRNA biogenesis and function, and was supported by a Jane Coffin Childs Research Fellowship. Since its establishment in 2006 research in the Gregory laboratory has focused on understanding molecular and cellular mechanisms controlling RNA biogenesis and decay and exploring the relevance of these pathways in stem cell pluripotency, mammalian development, and human disease. He was named a Pew Scholar, and a March of Dimes Basil O’Connor Scholar. He was Chair of the RNA mechanisms in cancer study section of the American Cancer Society, and is currently member of the scientific review council of the Pershing Square Cancer Research Alliance, and fellowship award selection committee of the Damon Runyon Cancer Research Foundation.

For more information on the work taking place in Dr. Gregory’s lab, please see the Gregory Lab section of this website and the Gregory lab home page at http://www.childrenshospital.org/research-and-innovation/research/labs/gregory-laboratory

 

 

Giving

Spotlight

  • The stem cell-cancer connection

    Two fundamental processes in biology—stem cell generation and carcinogenesis—are closely related. Richard Gregory, PhD, a principal investigator in the Stem Cell Program at Children’s Hospital Boston, is studying the nature of this link, and uncovering new approaches to enhancing stem cell creation as well as ways to inhibit cancer.